Turnkey Regenerative

Clinical science

Stem Cell Therapy and Exosomes in Orthopedic Medicine

Evidence calibration, regulatory standards and informed consent: terminology, product characterization, the condition-by-condition evidence for joints, tendon, bone and spine, the exosome translational gap, Section 361 and 351, IND boundaries, MedWatch reporting and chain of custody

Faculty: Sonya Pearson, Ph.D., J.D. and Mandy Hayes, FNP-C

Length
4 hours
Modules
8
Pass mark
80%
Credit
CEU and CME pending approval
Image: Dr James Edgar, Cambridge Institute for Medical Research, CC BY 4.0, via Wellcome Collection

Enrollment opens soon

Length
4 hours
Modules
8
Pass mark
80%

CEU and CME credit pending approval

Modules can be bought one at a time or as the full course.

What you will be able to do

  • Distinguish embryonic and adult stem cells, culture-expanded mesenchymal stromal cells, bone marrow aspirate concentrate and cell-free extracellular vesicles, and explain why cell-based and exosome products are separate biological and regulatory entities
  • Evaluate a cell or exosome product's source, isolation method, identity, purity, potency and stability documentation, and identify what a product dossier is missing
  • Grade the human evidence for cell-based injections in knee, hip and glenohumeral osteoarthritis, focal cartilage lesions and tendinopathy, separating trial results from mechanistic plausibility
  • Summarize the evidence for cellular adjuncts in femoral head osteonecrosis, fracture nonunion and intradiscal treatment of degenerative disc disease
  • Explain the gap between in vitro and animal exosome data and human clinical outcomes, including the effect of isolation and purification variability
  • Apply the Section 361 and Section 351 framework and the IND rules to an orthobiologic, and state when MedWatch and IND safety reporting apply
  • Conduct an informed consent discussion that states regulatory status, evidence certainty, alternatives and costs accurately, and document product chain of custody
  • Recognize deceptive orthobiologic marketing claims, including the claim that an active IND proves safety or efficacy, and replace them with accurate statements

Modules

  1. Module 1

    15 min

    Essential Terminology

    • Lesson 1.1Stem Cells, MSCs, BMAC and Exosomes: Four Different Things15 min
  2. Module 2

    30 min

    Biology and Product Characterization

    • Lesson 2.1Cell Sources and Isolation Methods15 min
    • Lesson 2.2Identity, Purity, Potency, Stability and the Missing Cargo Standard15 min
  3. Module 3

    45 min

    Condition-Specific Musculoskeletal Evidence

    • Lesson 3.1Knee Osteoarthritis: What the Trials Show18 min
    • Lesson 3.2Hip and Glenohumeral Osteoarthritis and Focal Cartilage Lesions14 min
    • Lesson 3.3Tendinopathy13 min
  4. Module 4

    35 min

    Bone Healing, Osteonecrosis and Spine

    • Lesson 4.1Femoral Head Osteonecrosis and Fracture Nonunion20 min
    • Lesson 4.2Intradiscal Cell Therapy for Degenerative Disc Disease15 min
  5. Module 5

    30 min

    Exosomes and the Translational Evidence Gap

    • Lesson 5.1From the Dish to the Joint: Where Exosome Evidence Stops15 min
    • Lesson 5.2Isolation and Purification Variability15 min
  6. Module 6

    30 min

    FDA Regulatory Status, Consent and Ethical Compliance

    • Lesson 6.1Section 361, Section 351 and the IND Boundary14 min
    • Lesson 6.2Informed Consent, Chain of Custody and MedWatch16 min
  7. Module 7

    30 min

    Case-Based Clinical Applications

    • Case: Case 1: An Uncharacterized Product for Knee Osteoarthritis10 min
    • Case: Case 2: Early-Stage Femoral Head Osteonecrosis10 min
    • Case: Case 3: Achilles Tendinopathy and a Marketing Claim10 min
  8. Module 8

    15 min

    Knowledge Assessment and Review

    • Lesson 8.1Review: Evidence Calibration on One Page5 min

Faculty

  • Sonya Pearson, Ph.D., J.D.

    Lead Author and Curriculum Development Director

  • Mandy Hayes, FNP-C

    Clinical Reviewer

Written for

  • Orthopedic surgeons
  • Sports medicine physicians
  • Physical medicine and rehabilitation physicians
  • Nurse practitioners and physician assistants in orthopedic and sports medicine practice

Facilitator backgrounds and credentials

To complete the course

  1. Acknowledge the scope of practice and FDA status notices
  2. Open every lesson in all eight modules and all three cases
  3. Score 80% or higher on the post-test
  4. Complete the course evaluation

Continuing education credit for this course is pending approval by an accredited provider. Until it is approved, no CE credit is awarded. Certificates are issued only for the full course; a single module does not earn one.

Content current as of October 2026.

This course is for educational purposes only. It is not medical, legal or regulatory advice and does not replace your own clinical judgment. Nothing in it recommends any product, supplier or treatment, or requires anyone to perform any procedure. No exosome product is FDA-approved, and no stem cell product is FDA-approved for any orthopedic condition; the biologics discussed are investigational except where an FDA approval is named, such as MACI for knee cartilage defects. Laws and scope of practice vary by state and license, so practice within yours.